文献速递前列腺癌

局灶HIFU后挽救性机器人前列腺癌根治术的可行性与结局

Salvage Robotic-assisted Laparoscopic Radical Prostatectomy Following Focal High-Intensity Focused Ultrasound for ISUP 2/3 Cancer.
PubMed 文献 · Urology · 2021-06-27

双中心研究比较局灶HIFU后挽救性机器人辅助腹腔镜根治性前列腺切除术(S-RALP)与初次同类手术(pRALP),按2:1匹配。S-RALP组13例、pRALP组26例,S-RALP并发症发生率46.2%(6/13)且Clavien-Dindo III级4例,但肿瘤学与功能结局一年时与pRALP相似。

要点

  • S-RALP可用于局灶HIFU后早期复发的ISUP 2/3前列腺癌患者
  • S-RALP的Clavien-Dindo III级并发症更多(4例),术前需告知
  • 术后一年功能结局(尿失禁P=.71,勃起功能P=.21)与pRALP无差异

核心结论

  • S-RALP应提供给局灶HIFU后早期复发的患者,早期肿瘤学结局满意且术后一年功能结局与pRALP相似。
  • 但S-RALP与更高的Clavien-Dindo III级并发症相关(主要为放置引流),术前应告知患者。

研究设计与样本

  • 双中心试验,纳入局灶HIFU前瞻性试验后接受S-RALP的ISUP 2/3前列腺癌患者,并按2:1匹配pRALP患者。
  • 共39例患者:S-RALP组13例,pRALP组26例。

主要发现

  • S-RALP组中位手术时间260分钟(pRALP:257分钟),出血量230ml(pRALP:300ml)。
  • S-RALP组并发症发生率46.2%(6/13),pRALP组26.9%;S-RALP组Clavien-Dindo III级并发症4例(pRALP:2/26)。
  • S-RALP组不良组织学结局(≥pT3a、pN+或R1)为23.1%(3/13)(pRALP:26.9%)。
  • S-RALP组有1例PSA持续(pRALP:2/26)。
  • 功能结局两组无差异(尿失禁P=.71,勃起功能P=.21)。

临床怎么用

  • 对局灶HIFU后早期复发的ISUP 2/3前列腺癌患者可考虑S-RALP。
  • 术前应告知S-RALP的Clavien-Dindo III级并发症风险较高(主要为放置引流)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report feasibility and outcome of salvage robotic-assisted laparoscopic radical prostatectomy (S-RALP) after focal therapy using high-intensity focused ultrasound (HIFU) treatment compared to primary robotic-assisted laparoscopic radical prostatectomy (pRALP). METHODS: In this bicentric trial patients undergoing S-RALP for detection of WHO2016/ISUP Grade Group 2 or 3 prostate cancer were previously treated in prospective focal HIFU trials. Perioperative data, complications, oncological and functional outcome were analysed. Patients who underwent pRALP were matched in a ratio 2(pRALP):1(S-RALP) according to preoperatively functional, oncological and clinical parameters. RESULTS: A total of 39 patients were included in the study (13S-RALP, 26pRALP). Median operative time in the S-RALP group was 260minutes (pRALP: 257minutes), blood loss was 230ml (pRALP: 300ml). Complications occurred in 46.2% (6/13) of S-RALP patients (pRALP: 26.9%), including four Clavien-Dindo III complications (pRALP: 2/26). In S-RALP adverse histological outcome (≥pT3a, pN+ or R1) was detected in 23.1% (3/13) (pRALP: 26.9%). There was one patient with PSA-persistence (pRALP: 2/26). Regarding functional outcomes there was no difference between the two groups observed (incontinence P=.71, erectile function P=.21). CONCLUSION: S-RALP should be offered to patients with an early relapse after focal HIFU. The early oncological outcome is satisfactory and functional outcome one year postoperatively is similar to pRALP. However, S-RALP is associated with a higher rate of Clavien-Dindo III complications (mainly, placement of a drainage), of which patients should be informed beforehand.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Spitznagel T, Hardenberg JV, Schmid FA, et al. Salvage Robotic-assisted Laparoscopic Radical Prostatectomy Following Focal High-Intensity Focused Ultrasound for ISUP 2/3 Cancer. Urology. 2021. PMID: 34186136. doi:10.1016/j.urology.2021.04.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。